ARVO meeting date:  April 29 – May 3, 2018

Honolulu Convention Center

1801 Kalakaua Avenue

Honolulu, Hawaii  96815

www.arvo.org

READ THE REPORTS

ANNOUNCEMENT:

The Lasker/IRRF Initiative for Innovation in Vision Science                        (SCROLL DOWN )

Since 2008, the Lasker Foundation and the International Retinal Research Foundation (IRRF) have been engaged in a partnership to accelerate discovery of sight-saving treatments and measures to prevent retinal degenerative diseases.  Chaired by John Dowling of Harvard University, the Initiative has produced four reports and one review article that identify knowledge gaps in research and apply innovative solutions to degenerative retinal diseases.

Please join members of this Initiative along with your colleagues at the 2018 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, where an expected 11,000 international basic and clinical researchers will share the latest breakthroughs in vision research. Two Special Interest Groups (SIGs) have been scheduled to present the findings of the Initiative and to mark the accomplishments of a decade of collaborative effort.

SIG One:  Monday, April 30, 1:30 to 3:00 PM, Ballroom B & C at the Convention Center.

Topics:  “Astrocytes and Glaucomatous Neurodegeneration.”  Panel members:  Claude F. Burgoyne, MD, Senior Scientist and Van Buskirk Chair for Ophthalmic Research, Discoveries in Sight Research Laboratories, Portland, Oregon; David J. Calkins, PhD, The Denis M. O’Day Professor of Ophthalmology and Visual Sciences, Vice-Chairman and Director for Research, Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee; Leonard A. Levin, MD, PhD, Professor and Chair of Ophthalmology, McGill University Health Centre, Montréal, Canada.

 

“Diabetic Retinopathy: Where We Are and A Path to Progress.”  Panel members:  Lloyd Paul Aiello, PhD, MD, Clinical Professor of Ophthalmology, Harvard Medical School and Founding Director of the Beetham Eye Institute, Boston, Massachusetts; Timothy Kern, PhD, Professor of Pharmacology and Director of the Center for Diabetes Research, Case Western Reserve University, Cleveland, Ohio; M. Francesca Cordeiro, MD, PhD, UCL Professor of Glaucoma and Retinal Neurodegeneration Studies, UCL Institute of Ophthalmology, London, England.

 

SIG Two:  Tuesday, May 1, 1:30 to 3:00 PM, Ballroom B & C at the Convention Center.

Topics:  “Restoring Vision to the Blind.”  Panel members:  Botond Roska, MD, PhD, Senior Group Leader, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; Jane Sowden, PhD, GOSHCC Professor in Developmental Biology and Genetics, Birth Defects Research Centre, UCL, London, England; Prof. Dr.med. Eberhart Zrenner, Distinguished Professor of Ophthalmology, Eberhard Karls University of Tübingen, Institute for Ophthalmic Research, Tübingen, Germany.

 

“Amblyopia: Challenges and Opportunities.”  Panel members: David G. Hunter, MD, PhD, Ophthalmologist-in-Chief, Boston Children’s Hospital, Professor and Vice Chair of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Lynne Kiorpes, PhD, Collegiate Professor of Neural Science and Psychology, New York University, New York, New York; Elizabeth Quinlan, PhD, Professor of Neuroscience and Cognitive Science, University of Maryland, College Park, Maryland.

CLICK HERE TO READ THE REPORT